NASDAQ:DOXAmdocs Stock Price, Forecast & News

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DOX shares have decreased by 7.1% and is now trading at $57.08. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Amdocs.

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Amdocs.

Amdocs Limited (NASDAQ:DOX) released its earnings results on Tuesday, February, 4th. The technology company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.01. The technology company earned $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a return on equity of 16.13% and a net margin of 11.99%. The company's quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the firm posted $0.98 EPS. View Amdocs' earnings history.

Amdocs declared a quarterly dividend on Tuesday, February 4th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.327 per share on Friday, April 24th. This represents a $1.31 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date is Monday, March 30th. This is a positive change from Amdocs's previous quarterly dividend of $0.29. View Amdocs' dividend history.

Amdocs updated its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $4.44-4.61 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.52. The company issued revenue guidance of $4.19-4.31 billion, compared to the consensus revenue estimate of $4.22 billion.

5 Wall Street analysts have issued 1-year price objectives for Amdocs' stock. Their forecasts range from $72.00 to $85.00. On average, they anticipate Amdocs' stock price to reach $77.80 in the next year. This suggests a possible upside of 36.3% from the stock's current price. View analysts' price targets for Amdocs.

Headlines about DOX stock have trended very negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Amdocs earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutAmdocs.

Amdocs saw a decrease in short interest in the month of March. As of March 13th, there was short interest totaling 3,580,000 shares, a decrease of 12.3% from the February 27th total of 4,080,000 shares. Based on an average trading volume of 1,117,400 shares, the days-to-cover ratio is currently 3.2 days. Approximately 2.7% of the shares of the company are short sold. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), Booz Allen Hamilton (BAH), EPAM Systems (EPAM), Gartner (IT), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), AT&T (T), QUALCOMM (QCOM), Home Depot (HD), Intel (INTC), Caterpillar (CAT), Enterprise Products Partners (EPD), Target (TGT), Verizon Communications (VZ) and Activision Blizzard (ATVI).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by many different retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.06%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.01%), Orrstown Financial Services Inc. (0.01%) and IBM Retirement Fund (0.00%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC.

DOX stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, IBM Retirement Fund, and Orrstown Financial Services Inc..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $57.08.

Amdocs has a market capitalization of $7.69 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe. View additional information about Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]